Forge Biologics

Columbus, OH
AAV
3 confirmed programs · 1 sponsors · Last scored 2026-04-29
62.7
Signal Score
○ FDA Inspections ✓ Clinical Trials (3) ○ SEC Filings ✓ Press (20) ○ EMA GMP ○ MHRA GMP

Quick Facts: Forge Biologics

Signal Score
62.7/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Columbus, OH
Modalities
AAV
Active Programs
3 confirmed from ClinicalTrials.gov across 1 sponsors
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Forge Biologics

AAV specialist. Acquired by Ajinomoto.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations 56.7
3 active programs across 1 sponsors
Modalities: AAV
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
3 active programs across 1 sponsors · Modalities: AAV · 2 programs in advanced phases (Phase 2/3)
Programs 3
Sponsors1
ModalitiesAAV
3 active programs across 1 sponsors
Modalities: AAV
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT06308718 Long-term Follow-up Study to Evaluate Safety and Efficacy of... NA Terminated
NCT05739643 Gene Transfer Clinical Trial for Infantile and Late Infantile... PHASE1/PHASE2 Active Not Recruiting
NCT04693598 Gene Transfer Clinical Trial for Krabbe Disease PHASE1/PHASE2 Active Not Recruiting
Source: ClinicalTrials.gov · Retrieved May 20, 2026
Financial Stability 75.0
Strong parent backing: Ajinomoto Bio-Pharma Services (acquired $620M)
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Strong parent backing: Ajinomoto Bio-Pharma Services (acquired $620M)
Capacity 58.0
Strong partnership activity (7 articles)
Sites: Columbus, OH
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
StatusExpanding
Strong partnership activity (7 articles)
Sites: Columbus, OH
Recent Press20 articles
Strong partnership activity (7 articles)

Recent News 20 articles

partnership 2026-05-06
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership - BioSpace
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership  BioSpace
Source →
general 2026-05-05
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and Manufacturing Pact - Contract Pharma
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and Manufacturing Pact  Contract Pharma
Source →
general 2026-05-05
Forge Biologics Highlights AAV Manufacturing Capabilities Ahead of ASGCT 2026 - TipRanks
Forge Biologics Highlights AAV Manufacturing Capabilities Ahead of ASGCT 2026  TipRanks
Source →
partnership 2026-05-05
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership - The Joplin Globe
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership  The Joplin Globe
Source →
general 2026-05-05
Forge Biologics Showcases AAV Manufacturing Capabilities Ahead of ASGCT 2026 - TipRanks
Forge Biologics Showcases AAV Manufacturing Capabilities Ahead of ASGCT 2026  TipRanks
Source →
partnership 2026-05-05
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership - Weekly Voice
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership  Weekly Voice
Source →
partnership 2026-05-05
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership - PharmiWeb.com
Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership  PharmiWeb.com
Source →
general 2026-04-30
Forge Biologics Showcases Gene Therapy Operations to Local STEM Students - TipRanks
Forge Biologics Showcases Gene Therapy Operations to Local STEM Students  TipRanks
Source →
general 2026-04-28
Forge Biologics Emphasizes European Gene Therapy Support and Regulatory Expertise - TipRanks
Forge Biologics Emphasizes European Gene Therapy Support and Regulatory Expertise  TipRanks
Source →
general 2026-04-23
Forge Biologics Among Select Global CDMOs to Earn My Green Lab® Certification Across All Laboratories and cGMP Suites - BioSpace
Forge Biologics Among Select Global CDMOs to Earn My Green Lab® Certification Across All Laboratories and cGMP Suites  BioSpace
Source →
general 2026-04-22
Forge Biologics Among Select Global CDMOs to Earn My Green Lab® Certification Across All Laboratories and cGMP Suites - Business Wire
Forge Biologics Among Select Global CDMOs to Earn My Green Lab® Certification Across All Laboratories and cGMP Suites  Business Wire
Source →
general 2026-04-18
Forge Biologics Highlights Manufacturing Challenges in Emerging Therapies - TipRanks
Forge Biologics Highlights Manufacturing Challenges in Emerging Therapies  TipRanks
Source →
general 2026-04-18
Forge Biologics Emphasizes Manufacturing Challenges in Emerging Therapies - TipRanks
Forge Biologics Emphasizes Manufacturing Challenges in Emerging Therapies  TipRanks
Source →
general 2026-04-09
Forge Biologics Targets Facilities Engineer to Support Manufacturing Infrastructure - TipRanks
Forge Biologics Targets Facilities Engineer to Support Manufacturing Infrastructure  TipRanks
Source →
general 2026-04-09
Forge Biologics Targets Facilities Engineering Hire to Support Manufacturing Infrastructure - TipRanks
Forge Biologics Targets Facilities Engineering Hire to Support Manufacturing Infrastructure  TipRanks
Source →
general 2026-04-07
Leadership Recognition Underscores Forge Biologics’ Gene Therapy Manufacturing Depth - TipRanks
Leadership Recognition Underscores Forge Biologics’ Gene Therapy Manufacturing Depth  TipRanks
Source →
general 2026-04-06
Forge Biologics Emphasizes Investor-Focused AAV Gene Therapy Manufacturing Strategy - TipRanks
Forge Biologics Emphasizes Investor-Focused AAV Gene Therapy Manufacturing Strategy  TipRanks
Source →
partnership 2026-03-26
Forge Biologics Recognition in CDMO Leadership Awards Signals Competitive Positioning - TipRanks
Forge Biologics Recognition in CDMO Leadership Awards Signals Competitive Positioning  TipRanks
Source →
general 2026-03-04
Forge Biologics Agrees to Develop and Manufacture Gene Therapy for Progeria - Genetic Engineering and Biotechnology News
Forge Biologics Agrees to Develop and Manufacture Gene Therapy for Progeria  Genetic Engineering and Biotechnology News
Source →
partnership 2026-03-03
Press Release Service: The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria - CRISPR Medicine News
Press Release Service: The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria  CRISPR Medicine News
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs →

Similar CDMOs

Cincinnati Children's Vector Production Facility
Cincinnati, OH
Signal Score: 75.2
AAV, Lentiviral
Andelyn Biosciences
Columbus, OH
Signal Score: 63.0
AAV
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid